Karavyraki 2022 MitoFit: Difference between revisions
(Created page with "link=Bioblast_2022 {{MitoFit page name}} {{Publication |title=Karavyraki M, Gnaiger E, Porter RK (2022) A comparison of bioenergetics in human...") ย |
No edit summary |
||
Line 3: | Line 3: | ||
{{Publication | {{Publication | ||
|title=Karavyraki M, Gnaiger E, Porter RK (2022) A comparison of bioenergetics in human tongue pre-cancerous dysplastic oral keratinocytes and squamous cancer cells. MitoFit Preprints 2022.22. https://doi.org/10.26124/mitofit:2022-0022 | |title=Karavyraki M, Gnaiger E, Porter RK (2022) A comparison of bioenergetics in human tongue pre-cancerous dysplastic oral keratinocytes and squamous cancer cells. MitoFit Preprints 2022.22. https://doi.org/10.26124/mitofit:2022-0022 | ||
|info=[[File:MitoFit Preprints pdf.png|left|160px|link= | |info=[[File:MitoFit Preprints pdf.png|left|160px|link=https://wiki.oroboros.at/images/0/0a/Karavyraki_2022_MitoFit.pdf|MitoFit pdf]] [https://wiki.oroboros.at/images/0/0a/Karavyraki_2022_MitoFit.pdf.pdf A comparison of bioenergetics in human tongue pre-cancerous dysplastic oral keratinocytes and squamous cancer cells] | ||
|authors=Karavyraki Marilena, Gnaiger Erich, Porter Richard K | |authors=Karavyraki Marilena, Gnaiger Erich, Porter Richard K | ||
|year=2022-06-02 | |year=2022-06-02 |
Revision as of 13:57, 2 June 2022
Karavyraki 2022 MitoFit
Karavyraki M, Gnaiger E, Porter RK (2022) A comparison of bioenergetics in human tongue pre-cancerous dysplastic oral keratinocytes and squamous cancer cells. MitoFit Preprints 2022.22. https://doi.org/10.26124/mitofit:2022-0022 |
ยป
Karavyraki Marilena, Gnaiger Erich, Porter Richard K (2022-06-02) MitoFit Prep
Abstract: Porter 2022 Abstract Bioblast: In an endeavour to understand the metabolic phenotype behind oral squamous cell carcinomas, we characterised the bioenergetic profile of a human tongue derived cancer cell line (SCC-4 cells) and compared this profile to a pre-cancerous dysplastic oral keratinocyte (DOK) cell line also derived from human tongue. The human SCC-4 cancer cells had greater mitochondrial densitydensity but lower mitochondrial O2 flow per cell than DOK cells. The lower oxygen consumption rate in SCC-4 cells can be partially explained by lower NADH-related enzymatic activity and lower mitochondrial Complex I activity when compared to pre-cancerous DOK cells. In addition, SCC-4 cells have greater extracellular acidification rate (an index of glycolytic flux) when compared to DOK cells. In addition, treatment with recombinant human IL-6 (rhIL-6), known to drive anoikis resistance in SCC-4 cells but not DOK cells, impairs oxygen consumption in SCC-4 but not DOK cells, without affecting mitochondrial density. We conclude that SCC-4 cells have a less oxidative phenotype compared to DOK cells and that IL-6 attenuates mitochondrial function in SCC-4 cells while increasing glycolytic flux.
โข O2k-Network Lab: AT Innsbruck Oroboros
Karavyraki Marilena, Gnaiger Erich, Porter Richard K
Data availability
- All data will be available.
Support
- Marie Curie Grant TRACT 721906 H2020-MCSA-ITN 2016; COST Action CA15203 MitoEAGLE (2016-2021). We thank Rafael Moreno-Sanchez for a constructive review of our manuscript.
Labels: MiParea: Respiration
Pathology: Cancer
Organism: Human
Preparation: Permeabilized cells Enzyme: Complex I, Marker enzyme, TCA cycle and matrix dehydrogenases Regulation: Aerobic glycolysis Coupling state: LEAK, ROUTINE, ET Pathway: S, ROX HRR: Oxygraph-2k
Bioblast 2022, Crabtree effect